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Abstract
The HIV-1 epidemic in sub-Saharan Africa is driven largely by heterosexual transmission of non-subtype B viruses, of which
subtypes C and A are predominant. Previous studies of subtype B and subtype C transmission pairs have suggested that a
single variant from the chronically infected partner can establish infection in their newly infected partner. However, in
subtype A infected individuals from a sex worker cohort and subtype B individuals from STD clinics, infection was frequently
established by multiple variants. This study examined over 1750 single-genome amplified viral sequences derived from
epidemiologically linked subtype C and subtype A transmission pairs very early after infection. In 90% (18/20) of the pairs,
HIV-1 infection is initiated by a single viral variant that is derived from the quasispecies of the transmitting partner. In
addition, the virus initiating infection in individuals who were infected by someone other than their spouse was
characterized to determine if genital infections mitigated the severe genetic bottleneck observed in a majority of
epidemiologically linked heterosexual HIV-1 transmission events. In nearly 50% (3/7) of individuals infected by someone
other than their spouse, multiple genetic variants from a single individual established infection. A statistically significant
association was observed between infection by multiple genetic variants and an inflammatory genital infection in the newly
infected individual. Thus, in the vast majority of HIV-1 transmission events in cohabiting heterosexual couples, a single
genetic variant establishes infection. Nevertheless, this severe genetic bottleneck can be mitigated by the presence of
inflammatory genital infections in the at risk partner, suggesting that this restriction on genetic diversity is imposed in large
part by the mucosal barrier.
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Introduction
Nearly 35 million people across the globe are infected with the
human immunodeficiency virus type 1 (HIV-1) and an additional
2.5 million new infections occur annually [1]. The current
pandemic is the result of viruses that are genetically diverse and
have been divided into 9 different subtypes (A–D, F–H, J, K) and
at least 28 circulating recombinant forms (www.hiv.lanl.gov).
Subtype B viruses predominate in North America and Western
Europe, and as a result, research efforts have focused primarily on
this subtype. However, almost 25 million individuals in sub-
Saharan Africa have been infected with non-subtype B viruses via
heterosexual transmission, leading to a significant gap in our
understanding of the most predominant HIV-1 variants world-
wide. In order to achieve protection against infection with a
globally effective vaccine, the origin and nature of variants that
establish a new infection must be better defined.
The mechanisms by which HIV-1 is transmitted sexually across
a mucosal barrier remain poorly understood. Characterization of
viral sequences in newly infected individuals has produced mixed
results. For instance, studies of individuals newly infected with
subtype B have demonstrated a relatively homogenous viral
population, suggesting infection by a single variant [2,3,4]. In
contrast, studies involving subtype-B virus transmission in a
population harboring sexually-transmitted diseases and subtype-A
virus in a sex-worker cohort suggest multiple viral variants can be
transmitted and are capable of establishing infection in a new host
[5,6,7,8]. Thus, the viral correlates of transmission are likely to be
influenced by subtype, study population, and route of infection.
Since only the newly transmitted virus population was character-
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ized in the majority of these studies, no information was available
regarding its relationship to the virus circulating in the
transmitting partner. Nevertheless, these studies indicate that
either a single viral variant or multiple variants can be transmitted
and establish a new HIV infection.
A previous study in this laboratory examined 8 epidemiolog-
ically linked heterosexual transmission pairs participating in a
HIV-discordant couple cohort in Lusaka, Zambia [9]. Seven of
these pairs harbored subtype C viruses, while the remaining pair
was infected with subtype G. In each transmission pair,
comparison of the virus population derived from the chronically
infected (donor) and newly infected partners (recipient) revealed a
severe genetic bottleneck during heterosexual transmission of
HIV, which was characterized by low sequence diversity in the
recipient. Moreover, the monophyletic nature of each recipient
virus population relative to the donor quasispecies indicated that
each was derived from a single variant within the donor.
Here we have expanded our studies of HIV-1 transmission to
include 12 additional transmission pairs from the Lusaka cohort
and 8 pairs from a similar cohort in Kigali, Rwanda [10,11]. The
predominant circulating subtypes in Lusaka and Kigali are
subtype C and subtype A respectively, providing a unique
opportunity in which to investigate the correlates of heterosexual
transmission in regions where the two most predominant HIV-1
subtypes circulate [12]. Each cohort is comprised of over 1,000
cohabitating HIV-discordant couples enrolled in a prospective
prevention study in which participants return at 3-month intervals
for preventive counseling and condom provision. Despite these
interventions, a low frequency of HIV-1 transmission still occurs
[13]. In the present study, plasma samples from HIV seronegative
partners were tested at each visit for the appearance of antibodies
to HIV-1 as well as for the presence of p24 antigen to identify
acutely infected individuals in whom virus is present in the
peripheral blood but antibody levels are still undetectable
[14,15,16]. Moreover, the studies presented here utilized end-
point dilution PCR (or single genome amplification (SGA)) to
compare partial env gene sequences within the quasispecies of the
donor and recipient. To investigate transmission in a setting
analogous to those that are associated with transmission of
multiple variants, we included a limited number of epidemiolog-
ically unlinked transmission events, in which the seronegative
partner was infected by someone other than their spouse. The
results indicate that, in the majority of cases, HIV-1 infection is
initiated by a single viral variant from a complex quasispecies in
the transmitting partner. The marked reduction in genetic
diversity that is observed during HIV-1 transmission appears to
be imposed in large part by the mucosal barrier, since this extreme
genetic bottleneck can be mitigated when inflammatory infections
are present in the recipient partner.
Results
A Severe Genetic Bottleneck Occurs During Subtype A
and C HIV-1 Transmission
HIV envelope sequences from twenty epidemiologically linked
heterosexual transmission pairs from the Lusaka and Kigali
cohorts were used for comparative sequence analysis of the donor
and recipient viruses (Table 1). Consistent with previous studies
[9,17], 10/12 transmission pairs from the Lusaka cohort were
identified as harboring subtype C envelope sequences. The
remaining two pairs were infected with subtype A (ZM292) and
a virus that could not be classified (ZM248), since env sequences
from the latter formed a distinct cluster that is equidistant from
known subtypes (data not shown). All of the 8 transmission pairs
from the Kigali cohort were identified as encoding subtype A Env
sequences (data not shown). Importantly, 14/20 of the newly
infected partners were identified as p24-positive or viral RNA-
positive prior to or on the date of seropositive testing and sample
collection from both partners, and for 11 of these subjects, the
samples analyzed were collected within an estimated 3–5 weeks
(17–40 days) following infection (Fiebig stages II–IV, [18]). These
pairs thus represent very recent transmission events (Table 1).
For each partner of a transmission pair, approximately 40 HIV-
1 env genes were amplified from uncultured PBMC DNA (20
amplicons) and plasma virus RNA (20 amplicons). SGA was
employed to minimize the potential for in vitro recombination
during the PCR reaction and re-sampling of genomes [19,20].
Each amplicon was directly sequenced over the V1–V4 region of
the HIV-1 envelope, the most variable region of the env gene.
Neighbor-joining phylogenetic trees were constructed using the
sequences derived from the 10 subtype C transmission pairs and
ZM248 (subtype unknown) (Figure 1A) and the 9 subtype A
transmission pairs (Figure 1B). Sequences from each donor-
recipient pair clustered together with high bootstrap support,
indicating a lack of cross-contamination from other samples or the
presence of related transmission networks. In each case the donor
sequences were heterogeneous, consistent with their derivation
from a chronically infected individual. Sequences from PBMC
DNA and plasma virus RNA were distributed throughout the
branch patterns of each donor and recipient, suggesting a lack of
observable compartmentalization between these two sources
(Figure 2A). In 18 of the 20 transmission pairs, recipient envelope
sequences were homogenous forming a distinct monophyletic
subcluster within the branch pattern of the donor sequences. This
is consistent with our previous study [9] demonstrating that a
single genetic variant from the donor quasispecies initiates
infection in the recipient and with more recent analyses of subtype
B HIV-1 acutely infected individuals [21].
In contrast, recipient sequences in the remaining two pairs
(RW57 and ZM229) were not monophyletic. Examination of the
neighbor-joining tree for RW57 (Figure 2A) reveals 2 distinct, but
Author Summary
Previous studies of HIV transmission have yielded conflict-
ing results regarding the genetic heterogeneity of the virus
establishing infection in the newly infected individual. In
this study of populations from Zambia and Rwanda that
are infected by two distinct viral genetic subtypes, we
compared viral sequences that encode the entry-mediat-
ing envelope glycoproteins from newly infected individu-
als (recipients) and their spouses (donors) very early after
infection, as well as newly infected individuals infected by
someone other than their spouse. In spite of the
genetically diverse virus population in the donor, approx-
imately 90% of newly infected individuals were infected by
a single viral variant, while the rest were infected by
multiple viral variants. The homogeneity of the virus
population in the newly infected recipient, as well as the
presence, in some cases, of identical virus variants in the
donor, allowed us to precisely identify the transmitted
variant. We were able to examine the clinical history of
each newly infected individual and observed that all
individuals infected by multiple variants also showed
evidence of inflammatory genital infections. Our results
suggest that the genital mucosa provides a natural barrier
to infection by multiple genetic variants of HIV-1, but that
this barrier can be lowered by inflammatory genital
infections.
Bottleneck in HIV-1 Transmission
PLoS Pathogens | www.plospathogens.org 2 January 2009 | Volume 5 | Issue 1 | e1000274
highly related subclusters of viral sequences for RW57F that are
derived from a subset of RW57M sequences. The two variant
populations in RW57F differ by a cluster of five synonymous
mutations in the V1 region of gp120 that differentiate the seven
sequences of cluster 2 from the 35 in cluster 1 (Figure S1A).
Moreover, these signature sequences in cluster 2 are shared by two
of the donor env genes, indicating that they did not arise de novo in
the recipient. The branching pattern and the presence of two
distinct populations of sequences that cannot be explained by viral
evolution (see below), suggests that 2 different but closely related
viral variants were involved in the establishment of infection in
RW57F. The neighbor-joining tree for couple ZM229 (Figure 2B)
showed recipient sequences forming 4 distinct branches within the
donor sequences. This branching pattern again suggests that
multiple viral variants, 4 in this case, were involved in establishing
the infection in ZM229M. This is consistent with the analysis of
the recipient sequences reported by Salazar et al. [20]. Thus, while
a single donor variant establishes infection in 90% of the
transmission events, RW57F and ZM229M demonstrate that
multiple variants can be transmitted and establish infection.
Moreover, these two cases demonstrate that a single most-fit
genetic variant does not necessarily evolve to dominate the acute
viral population.
To evaluate the extent of sequence diversity in the newly
infected individuals, V1–V4 sequences from the recipient were
examined using the Highlighter tool on the Los Alamos National
Laboratory website. This tool allows a comparison of each
recipient Env sequence to a reference recipient sequence and
graphically depicts any nucleotide differences between the two.
Examples of the output from this tool for one subtype C and one
subtype A recipient are given in Figure 3A and 3B. A remarkable
degree of homogeneity is observed in the V1–V4 sequences for
ZM243F (Figure 3A), where infection was estimated to have
occurred 26 days prior to sample collection and where
approximately 80% (36 of 45) of the sequences are identical
despite each being amplified from a unique viral genome. Similar
numbers of identical sequences were observed in both plasma (21)
and PBMC (15) derived sequences. Compared to the reference
Table 1. Samples Collected for Analysis.
Recipient ID Sample Date
Estimated Days from
Infection MRCA (Days) Envelope Subtype
Linked to Enrolled Partner
ZM229M 19-Oct-02 ,94 1409 C
ZM238M* 29-Oct-02 40 5 C
ZM242F* 25-Jan-03 31 30 C
ZM201M* 7-Feb-03 31 35 C
ZM221M* 7-Mar-03 31 23 C
ZM205F* 27-Mar-03 48 19 C
ZM248F* 5-Jun-03 79 108 Unknown
ZM190F* 6-Dec-03 31 15–30+ C
ZM216M* 17-Jan-04 31 66 C
ZM198F* 4-Mar-04 78 126 C
ZM243F* 9-Mar-04 26 24 C
RW41M 21-Jan-05 ,94 26–52+ A1
RW19F 2-Feb-05 ,96 26–35+ A1
RW35M 28-Feb-05 ,96 47–59+ A1
RW36M 7-Mar-05 ,86 21 A1
RW56F# 21-Apr-05 17 18 A1
ZM292M* 24-May-05 28 44 A1
RW53F* 29-Jun-05 35 35 A1
RW57F 12-Oct-05 ,94 166 A1
RW67M* 23-Mar-06 37 41 A1
Unlinked to Enrolled Partner
ZM215F 3-Oct-02 ,92 2625 C
ZM197M# 29-Oct-02 17 17 C
ZM224F 5-Nov-02 ,134 568 C
ZM233M 17-Dec-02 ,110 36 C
ZM184F 10-Jul-03 ,92 31 C
ZM249M* 12-Aug-03 29 21 C
ZM247F* 1-Nov-03 26 536 C
*Individuals identified as p24-positive.
#Individuals identified as viral RNA-positive.
+Range of values indicate a higher than predicted rate of G to A mutations consistent with APOBEC3G/F signatures.
doi:10.1371/journal.ppat.1000274.t001
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amplicon (PB_1), approximately 11% of the sequences exhibited a
single nucleotide change randomly dispersed over the V1–V4
region, and 7% two nucleotide changes. One amplicon (PB_23)
exhibited a three-codon deletion in the V4 region. Similarly, for
RW19F (Figure 3B), where infection was estimated to be 26–35
days before sample collection (see below), approximately 68% of
the sequences are identical, 28% contained a single base change
and 5% two nucleotide changes compared to the reference
amplicon (PB_B8A). These frequencies are consistent with a
model where infection is initiated by a single donor genetic variant
that undergoes base mis-incorporation at a rate of 1.761025 per
day or 3.461025 per replication cycle [20]. The model used to
calculate the most recent common ancestor is based on this
observation and yields a Poisson distribution of mutations with
star-like phylogeny [21].
For each set of the recipient sequences, we calculated the
number of days required to explain the observed within patient env
diversification from a single most recent common ancestor
(MRCA) sequence as described previously (Table 1, [21]). Four
of the recipients (ZM190F, RW19F, RW35M, RW41M) showed a
higher than predicted rate of G to A mutations that occurred in
sequences consistent with APOBEC3G/F signatures. For these
individuals we calculated the time to MRCA with and without
these mutations and expressed the time frame as a range of days.
This is exemplified by Figure 3B where 4 G to A mutations
(circled) occurred in sequences consistent with an APOBEC
signature. A majority (16/20) of the calculated days from the
MRCA agreed closely with the estimated time from infection
based on patient history and Fiebig stage of infection [18]. By
contrast, both ZM229 and RW57 showed MRCA calculations
that exceeded the estimated time to infection consistent with the
transmission of multiple variants as identified through phyloge-
netic and Highlighter analyses (Figure 2, Figure S1A and B). This
was particularly notable for ZM229, where the MRCA calcula-
Figure 1. Phylogenetic analysis of heterosexual transmission pairs. Nucleotide sequences were aligned for all linked donors (green lines)
and linked recipients (blue lines) and neighbor-joining trees were drawn representing (A) subtype C transmission pairs and (B) subtype A
transmission pairs. Recipients in red indicate infection by multiple variants. Horizontal branch lengths are drawn to scale with scale bar representing
2% divergence. Asterisks indicate branches with bootstrap values greater than 0.99. Black lines represent unrelated reference sequences.
doi:10.1371/journal.ppat.1000274.g001
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tion, which exceeds 1400 days, reflects the genetic heterogeneity of
infection by multiple variants. Two other individuals, ZM216 and
ZM292, exhibited times to MRCA double that estimated from
their Fiebig stage of infection. Approximately one third of the Env
sequences from patient ZM216 showed evidence of early CTL
escape, characterized by a cluster of non-synonymous mutations in
a single 9 amino acid region (Figure S2A), similar to those we have
described previously [20] – similar CTL-escape footprints were
observed in a smaller fraction of sequences in ZM248F, RW41M,
and RW35M. For ZM292M approximately one third of the env
sequences exhibited a common 2-codon deletion in the ß14 region
of gp120 (Figure S2B), raising the possibility that two closely
related variants were associated with transmission. However,
based on the fact that all of the ZM292M sequences are derived
from a single branch of the donor phylogenetic tree and that this
deletion was not present in any of the 40 donor sequences, we
hypothesize that this variant represents an early stochastic RT
error that conferred some fitness advantage during acute infection.
To quantify the genetic variation observed for the viral
quasispecies within each of the newly infected recipients, the
pairwise distance was calculated for the nucleotide sequences in
each recipient virus population (Figure 3C). As might be predicted
from the phylogenetic analyses, in 19 of the 20 recipient virus
populations the calculated median pairwise distance was extremely
low, and in all but the 4 cases where CTL escape or APOBEC
signatures were evident even the most divergent variants in the
population differ by less than 1%. In the case of RW57F, the more
divergent variants were consistent with more than one closely
related variant being transmitted. The most dramatically different
pattern observed was with ZM229M, for which the median
pairwise distance was over 2%, and the most divergent variants
differed by almost 11%, consistent with multiple distinct variants
from a single donor being involved in establishing infection.
Taken together, these results suggest that in a majority of cases
where heterosexual transmission occurs within an HIV-1 discor-
dant couple, a severe genetic bottleneck restricts viral diversity,
with a highly homogeneous population representative of the
initiating virus variant predominating early after infection.
Relationship of Recipient Viruses to the Donor
Quasispecies
Because in a majority of cases a single donor variant establishes
infection, we sought to determine the frequency of this variant or
closely related variants in the donor quasispecies and to examine
whether such variants predominated in plasma or PBMC derived
viruses in the donor. The application of single genome PCR
amplification and analysis of approximately 20 plasma and 20
PBMC viruses for each donor allows this question to be
approached with increased confidence. The number of amino
acid differences between each donor virus sequence and the
consensus recipient virus sequence were calculated for each of the
10 linked transmission pairs where Fiebig stage and MRCA
Figure 2. Transmission of multiple variants. Aligned nucleotide sequences for linked donors (green circles) and linked recipients (blue circles)
were used to generate neighbor-joining trees for individual transmission pairs (A) RW57 and (B) ZM229. Horizontal branch lengths are drawn to scale
with scale bar representing 1% divergence. Open circles represent sequences derived from uncultured PBMC DNA and closed circles represent
sequences derived from plasma RNA. PBMC samples were unavailable for ZM229; therefore, only plasma sequences were derived for this
transmission pair. Asterisks indicate branches with bootstrap values greater than 0.99.
doi:10.1371/journal.ppat.1000274.g002
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calculations estimated infection to have occurred less than 50 days
previously. In 8 of the 10 transmission pairs analyzed, at least one
donor variant was identified that differed by fewer than 5 amino
acids from the consensus recipient variant over the approximately
250 amino acid V1–V4 region (Table 2). In two cases, ZM221M
and RW53F, a single viral variant in the donor quasispecies was
identified whose amino acid sequence is identical to the consensus
observed in the recipient, and in one other case (ZM242F) the
most closely related donor variant differed by 1 amino acid from
the recipient consensus. For these ten transmission pairs, the donor
variants most closely related to the recipient sequences were
derived from both plasma (4/10) and PBMC (6/10) samples.
Therefore, in terms of the peripheral blood, it is not possible to
establish whether the infecting virus is specifically derived from a
single compartment – for example latently infected PBMC.
The number of variants identified within each donor that
contain fewer than 5 amino acid differences was determined for
each transmission pair (Table 2). In 9 of the 10 transmission pairs,
2 or fewer variants (less than 5% of the donor sequences) were
closely related (.98%) to variants identified in the recipient. This
analysis suggests that in most transmission pairs, the virus
establishing infection is derived from an infrequent variant
population within the donor sequences derived from blood at
the time samples were collected.
Mitigation of the Severe Genetic Bottleneck
In contrast to the results presented above, analyses of newly
infected sex workers in Kenya and STD clinic participants in
North Carolina suggested that, in up to 50% of cases, multiple
variants established new infections [5,6,7,8]. This raised the
Figure 3. Homogenous virus population in newly infected individuals. Aligned linked recipient sequences were analyzed by the Highlighter
tool (Los Alamos National Laboratory website - HIV Sequence Database), examples of output files are shown for (A) ZM243F and (B) RW19F. Tic
marks indicate nucleotide differences from the indicated master sequences derived from the recipient. Nucleotide differences are color-coded and
are marked according to their genetic location along the length of V1–V4. Colors are as follows: A: green, T: red, G: yellow, C: blue and gaps: gray. Tics
highlighted by circles represent G to A changes in a sequence consistent with an APOBEC3G/F signature. (C) Box plots were generated using the
pairwise distances calculated for individual linked recipients. Horizontal lines within box plots indicate median pairwise distance values for each
linked recipient. Red boxes indicate individuals infected by multiple genetic variants.
doi:10.1371/journal.ppat.1000274.g003
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question of whether the factors involved in epidemiologically
linked transmissions in the discordant couple cohorts are
intrinsically different from more broadly exposed populations.
Because in the Kenya studies a link existed between sexually
transmitted infections (STIs) and virus heterogeneity in the newly
infected participant, we analyzed a subset of newly infected
individuals within the cohort who had been infected outside the
cohabiting partnership, and who might therefore be at higher risk
of STIs. A total of 7 epidemiologically unlinked recipients were
identified from the Lusaka cohort for sequence analysis of the HIV
envelope (Table 1). Three of the 7 unlinked individuals were
identified as p24-positive or virus RNA positive and samples were
obtained very near the time of infection. Single genome
amplification was used to generate approximately 20 HIV-1
envelope amplicons from plasma virus RNA of each unlinked
recipient. Each envelope amplicon was directly sequenced over the
V1–V4 region and a neighbor-joining phylogenetic tree was
constructed from the sequences (Figure 4A). Viruses in each of the
7 unlinked recipients were identified as subtype C (data not shown)
and their env sequences were monophyletic indicating that each
had been derived from a single unidentified donor partner. The
sequences in four of the unlinked recipients were highly
homogenous (ZM184F, ZM249M, ZM197M, ZM233M) similar
to that observed in the linked recipients. In contrast, three of the
unlinked recipients (ZM224F, ZM247F, ZM215F) have a highly
diverse virus population, where multiple divergent branches
appear to be present. The Highlighter Tool output for ZM247F
is shown in Figure 4B and clearly displays two distinct variants that
exhibit a large number of nucleotide differences from each other
within the newly infected individual, consistent with at least 2 viral
variants being involved in the establishment of infection in this
individual. Similar analyses for ZM224 and ZM215 (Figure S1C
and D) indicate that in each of these cases at least two distinct
variants from a single unidentified donor initiated infection in the
unlinked recipient.
To further quantitate the genetic diversity in the seven unlinked
individuals, nucleotide pairwise distances were calculated for the
sequences within each subject (Figure 4C). As might be predicted
from the phylogenetic analysis, the pairwise distance calculations
for ZM224F, ZM247F and ZM215F show that the virus
quasispecies in each of these recipients are very heterogeneous,
differing from each other by as much as 13%. This is a level of
heterogeneity that far exceeds that predicted from RT-based
misincorporation within the maximum estimated time from
infection. The 4 remaining unlinked recipients harbored highly
homogeneous virus populations with less than 0.5% divergence.
We also performed MRCA calculations for the seven unlinked
individuals as was performed for the linked recipients (Table 1).
The four unlinked individuals with highly homogeneous virus
(ZM184F, ZM249M, ZM197M, ZM233M) showed MRCA
calculations consistent with the estimated time of infection.
However, ZM224F, ZM247F and ZM215F exhibited time-to-
MRCA calculations that were between 4 and 28 times longer than
the estimated time from infection (Table 1). This is again
consistent with the level of heterogeneity observed in the
phylogenetic, Highlighter and pairwise-distance analyses. Taken
together these results suggest that in 3 of the 7 unlinked recipients
(42.9%), infection was established by multiple viral variants. While
the numbers of individuals analyzed is small, this does represent a
frequency significantly higher than that observed in the linked
transmission pairs (Table 3; p = 0.0211). Initial studies in a
Kenyan sex worker cohort suggested that heterogeneous virus
populations were more common in newly infected females [5], but
additional studies showed evidence of heterogeneous virus
populations in both newly infected females and males [8]. An
analysis of the association of multiple variants and gender in this
study did not reveal any statistical significance (Table 3).
Thus, in the context of both linked and unlinked transmissions,
conditions do exist that mitigate the genetic bottleneck, allowing
for transmission of multiple variants. However, this occurred more
frequently in the unlinked recipients. An analysis of the clinical
history for each of the 7 unlinked recipients showed a significant
association (p= 0.0286) between the presence of vaginal/urethral
discharge, which is evidence of an inflammatory genital infection,
and the establishment of infection by more than one genetic
variant in the three females in which this was present (Table 4).
Lower abdominal pain in the newly infected recipient was also
significantly associated with multiple genetic variants establishing
infection in the unlinked recipients (p = 0.0286; Table 4).
This analysis of clinical histories was expanded to include a total
of 42 newly infected individuals for whom we had established
whether infection in the recipient was initiated by a single or
multiple genetic variants from the donor, in order to identify any
significant associations between clinical criteria and the establish-
ment of infection by more than one genetic variant. This group
included the 27 newly infected individuals presented here, and
fifteen, additional linked recipients that have been described
[9,21]. Interestingly, when these 42 recipients were subjected to
Table 2. Relationship of donor variants to recipient consensus sequence.
Recipient ID
Number of Donor
Variants Analyzed
Number of Amino Acid
Differences from Recipient
Blood Compartment of Origin
of Nearest Donor Variant
Number of Donor Sequences
,5 amino acids different
ZM221M 36 0 PBMC 1
RW53F 39 0 PBMC 1
ZM242F 37 1 Plasma 6
ZM238M 38 2 PBMC 1
ZM243F 36 3 Plasma 2
RW56F 40 3 PBMC 1
RW67M 41 3 Plasma 2
ZM201M 37 4 Plasma 1
ZM190F 35 10 PBMC 0
ZM205F 45 11 PBMC 0
doi:10.1371/journal.ppat.1000274.t002
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Figure 4. Analysis of unlinked recipients. (A) Aligned nucleotide sequences for 8 unlinked recipients were used to generate a neighbor-joining
phylogenetic tree. Horizontal branch lengths are drawn to scale, with scale bar representing 2% divergence. Lines drawn in blue indicate individuals
infected by a single variant, those in red indicate infection by multiple variants. Asterisks indicate branches with bootstrap values greater than 0.95.
Bottleneck in HIV-1 Transmission
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analysis, all 5 recipients characterized as having been infected by
multiple genetic variants showed evidence of genital inflammation
(3 females) or ulceration (1 male, 2 female) (Table 4). Moreover,
the presence of genital inflammation or ulceration was significantly
associated with the presence of multiple genetic variants in the
recipient (p = 0.0492). Similarly, the presence of lower abdominal
pain in the recipient was also significantly associated with multiple
variants establishing infection (p = 0.0299) (Table 4).
Discussion
A Severe Genetic Bottleneck During Heterosexual
Transmission of HIV-1
In studies that have characterized the virus population in newly
infected individuals, the complexity of the virus is higher in some
cohorts than in others. Most of these studies were unable to
examine the viral population of the sexual partner of that
individual. The samples used in the studies presented here were
collected from both the chronically infected donor and the newly
infected recipient partner enrolled in discordant couple cohorts in
Lusaka, Zambia and Kigali, Rwanda. This has provided a unique
opportunity to compare epidemiologically linked virus populations
in both the donor and recipient very near the time of virus
transmission and to use this information to define the nature and
origin of the virus establishing infection. The studies presented
here reinforce our previous finding that a severe genetic bottleneck
occurs during heterosexual transmission of subtype C HIV-1 [9].
In a majority (90%) of linked subtype C and subtype A
transmission pairs, a single viral variant or a single virus infected
Table 3. Multiple Variants Association.
Single Variant Multiple Variants p value*
n % n %
Gender of seroconverter - Lusaka
Female 17 54.8% 3 75.0% 0.6272
Male 13 41.9% 1 25.0%
Gender of seroconverter - Kigali
Female 3 42.9% 1 100.0% 1.0000
Male 4 57.1% 0 0.0%
Linkage - Lusaka
Unlinked 4 12.9% 3 75.0% 0.0211
Linked 26 83.9% 1 25.0%
*p-value calculated using Fisher’s exact test.
doi:10.1371/journal.ppat.1000274.t003
Black lines indicate unrelated reference sequences. (B) Aligned linked recipient sequences were analyzed by the Highlighter tool (Los Alamos
National Laboratory website - HIV Sequence Database), an example of the output file is shown for ZM247F. Tic marks indicate nucleotide differences
from the indicated master sequences derived from the recipient. Nucleotide differences are color-coded and are marked according to their genetic
location along the length of V1–V4. Colors are as follows: A: green, T: red, G: yellow, C: blue and gaps: gray. (C) Box plots were generated using the
pairwise distances calculated for individual unlinked recipients. Horizontal lines within box plots indicate median pairwise distance values for each
unlinked recipient. Red boxes indicate individuals infected by multiple genetic variants.
doi:10.1371/journal.ppat.1000274.g004
Table 4. Prospective evaluation of clinical signs/symptoms of STIs on the day of and last seronegative visit prior to seroconversion.
Zambia Unlinked Zambia+Rwanda
Single (N=4) % Multiple (N=3) % p-value* Single (N=37) % Multiple (N=5) % p-value*
Genital inflammation
No 3 75.0% 0 0.0% 0.1429 25 67.6% 2 40.0% 0.3295
Yes 1 25.0% 3 100.0% 12 32.4% 3 60.0%
Genital ulceration
No 3 75.0% 2 66.7% 1.0000 29 78.4% 2 40.0% 0.1028
Yes 1 25.0% 1 33.3% 8 21.6% 3 60.0%
Genital inflammation or ulceration
No 2 50.0% 0 0.0% 0.4286 20 54.1% 0 0.0% 0.0492
Yes 2 50.0% 3 100.0% 17 45.9% 5 100.0%
Discharge
No 4 100.0% 0 0.0% 0.0286 28 75.7% 2 40.0% 0.3249
Yes 0 0.0% 3 100.0% 9 24.3% 3 60.0%
Cystitisa
No 4 100.0% 2 66.7% 0.4286 31 88.6% 4 80.0% 0.5066
Yes 0 0.0% 1 33.3% 4 11.4% 1 20.0%
Lower abdominal pain (self report)a
No 4 100.0% 0 0.0% 0.0286 31 88.6% 2 40.0% 0.0299
Yes 0 0.0% 3 100.0% 4 11.4% 3 60.0%
*p-value calculated using Fisher’s exact test.
a2 Zambia subjects missing data on cystitis and lower abdominal pain because seroconversion detected between screening and enrollment visits.
doi:10.1371/journal.ppat.1000274.t004
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cell established each new infection (Figure 1), as supported by
phylogenetic and Highlighter analyses of donor and recipient viral
sequences, as well as MRCA calculations for each recipient virus
population. Thus, viruses circulating in 2 distinct geographic
locations and ethnic communities exhibit a severe genetic
bottleneck during heterosexual transmission, irrespective of virus
subtype or host genetic background. Furthermore, our ability to
examine the sequences from 10 individuals during acute infection
demonstrated how remarkably homogeneous the virus population
is at this time (Figure 3). The consensus sequence observed soon
after infection can therefore inform us as to the variant that
established infection in the new host. This is consistent with and
supports the recent results of Keele et al. who have characterized
early isolates of subtype B HIV-1 [21].
Variants could be identified within the donor quasispecies that
were identical (ZM221 and RW53) or highly related (less than 2%
amino acid differences) to the variant establishing infection in the
recipient in several transmission pairs (Table 2). However, the
‘‘transmitted’’ donor variants generally represented a small fraction
(less than 5%) of the donor quasispecies rather than being the
predominant population circulating within the peripheral blood. An
analysis of genetic variants in the donor’s genital fluids in a subset of
these same transmission pairs at the time infection was detected, has
indicated that the virus that establishes infection, is in most cases,
more related to blood-derived variants than those enriched in the
genital compartment (Boeras et al., manuscript in preparation). In
the present study, these ‘‘transmitted’’ donor variants were detected
with approximately equal frequency among sequences from PBMC
DNA or plasma viral RNA. Thus, within the sampling constraints of
this large cohort study, we were unable to distinguish between the
cell-free, plasma-derived virions and cell-associated virus as the
source of the new infection. Nevertheless, the finding of identical
and highly related variants within the donor confirms that the newly
transmitted virus existed in the donor quasispecies prior to
transmission, and therefore did not result from very early de novo
viral evolution in the new host.
A previous study in this laboratory reported that the genetic
bottleneck involved a selection for variants with length-constrained
hyper-variable domains compared to the median of corresponding
donor sequences [9]. In that study, viral sequences were predomi-
nantly derived from PBMC DNA to capture the entire spectrum of
genetic diversity in the donor. An analysis of the single genome
amplified viral sequences derived from PBMC DNA from the 10
subtype C transmission pairs presented here have yielded results
consistent with the previous study in that the majority of recipient
viruses encode more compact V1–V4 regions compared to the donor
median (Haaland et al, manuscript in preparation). In contrast, a
similar comparison of donor and recipient PBMC-derived Env
sequences from the 9 subtype A transmission pairs described here and
an additional 12 pairs analyzed independently showed no significant
differences in V1–V4 (or V1–V2) length between donors and
recipients (Haaland et al, manuscript in preparation). The subtype A
results differ from a previous study of newly infected Kenyan sex
workers, in which a statistically significant difference was observed in
V1–V2 length compared to sequences from chronically infected
individuals found in the Los Alamos National Laboratory’s HIV
Sequence Database [22]. These conflicting results raise the possibility
that subtype A sequences from different geographical regions, such as
Kenya and Rwanda, may have inherent differences in this regard.
Mitigation of the Severe Genetic Bottleneck
In only a minority (10%) of the linked transmission events
examined, were recipient sequences present on multiple branches
of the donor phylogenetic tree (ZM229 and RW57; Figure 2),
indicative of more than one donor variant being transmitted. In
contrast, an analysis of 7 ‘‘unlinked’’ recipients from the Lusaka
cohort suggested that transmission of multiple variants is more
common in this setting (Figure 4). Three individuals were infected
with at least two variants, and this represented a statistically
significant increase in the frequency of infection by multiple
variants in this study population compared to the linked
transmission pairs (Table 3).
The criteria used to confirm that multiple genetic variants
established infection are defined in detail in Protocol S1. These
included (i) the absence of a Poisson distribution of mutations with
star-like phylogeny resulting in MRCAs that significantly exceeded
the maximum estimated date of infection, (ii) distinct populations
of sequences in the highlighter analysis that could not be readily
explained by selection of CTL escape variants, and (iii) in the case
of transmission pairs more than one branch of recipient sequences
emanating from the donor tree. While 4/5 of the individuals
infected with multiple variants have an estimated date of infection
that exceeds 90 days (Table 1), this reflected the lack of a p24
positive date with which to define a more accurate estimate of the
time of infection and required that we instead calculate the time
from the last seronegative visit to the first seropositive visit.
Nevertheless infection could have occurred at any point during
this period. Indeed for six individuals infected with a single variant
for whom a p24 positive date was not available, and whose
estimated date of infection exceeded 85 days, the MRCA estimates
were between one third and one half the estimated time of
infection (31–47 days; Table 1). Moreover, even the longest
estimated time of infection could not explain the level of
heterogeneity observed in the env sequences from these individuals
or the presence of between two and five subsets of sequences in
which the members exhibit multiple identical nucleotide differ-
ences (Figure 4 and Figure S1).
Since the exact time of infection is not known for any of the
partners in the ZEHRP or PSF cohorts, we cannot definitively rule
out the possibility that some of those individuals who were
classified as infected by ‘‘multiple’’ variants may have in fact been
superinfected through multiple sexual acts with the same partner.
However, the frequency of transmission in the ZEHRP cohort (7
per 100 person years) is 1 in 300 to 1 in 600 unprotected coital acts
[11 and unpublished], and so it would be unlikely that two
independent transmissions would occur within the last seronega-
tive to first seropositive time frame.
The observation, that multiple variants established infection at a
higher frequency following epidemiologically unlinked transmission,
suggested that factors capable of mitigating the severity of the genetic
bottleneck could be more common in these cases. Examination of the
clinical history of the newly infected partner in unlinked pairs
revealed a striking association between the presence of multiple
variants and vaginal/urethral discharge or lower abdominal pain
(Table 4). As the numbers of transmission events for the unlinked
recipients is small, this analysis was extended to include all newly
infected individuals examined from the Rwanda and Zambia cohorts
to date. While the presence of multiple variants in the newly infected
partner no longer correlated with the presence of vaginal or urethral
discharge, it was significantly correlated with lower abdominal pain
and the presence of genital inflammation or ulceration (Table 4).
Furthermore, in these cohorts, gender does not predispose an
individual to being infected by more than one variant (Table 3). The
association between genital tract infections and multiple variants is
consistent with a previous study in a subtype A infected Kenyan
female sex worker cohort [23]. These investigators established
significant correlations between the presence of sexually transmitted
diseases (STDs) and multiple infecting variants, but they also
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observed that over 90% of individuals with multiple variants had
signs of a genital tract infection. This observation may account for the
high frequency of heterogeneous virus present in newly infected
individuals in sex-worker cohorts [5,8], or those identified in a STD
clinic [6], since both of these groups are likely to display a higher
frequency of STDs than monogamous transmission pairs.
Genital tract inflammation could compromise the mucosal
barrier during sexual exposure such that multiple variants can be
transmitted and ultimately establish a systemic infection. While
HIV-1 transmission from a chronically infected individual to their
partner has been documented to be a relatively rare event (1 in 300–
1000 unprotected sexual acts, [11,13,24,25]), multiple studies have
suggested that the presence of STDs in the at-risk individual
increases susceptibility to HIV-1 infection [reviewed in 26,27].
Genital tract infections could produce lesions in the mucosal surface
that would increase access of virus to underlying target cells, thereby
increasing the probability that multiple variants would gain access to
distant sites and establish a systemic infection. Additionally, genital
inflammation could provide an influx of activated potential target
cells to the genital mucosa. It should be noted, however, that in a
majority of HIV-1 transmission events, infection by a single variant
occurs in the absence of diagnosed genital disease, arguing that
HIV-1 can successfully cross the mucosal surface in the absence of
such mucosal insults. This is consistent with previous epidemiolog-
ical studies in the ZEHRP cohort [13].
Nature of the Severe Genetic Bottleneck
Studies in rhesus macaques in which relatively large doses of a
virus quasispecies have been applied to hormonally thinned vaginal
mucosa showed that multiple viruses initiate a localized infection,
but that only a subset is able to establish a systemic infection [28,29].
These studies suggest that multiple variants may be able to initiate
foci of infection within the genital compartment, but only a fraction
of these can extend the infection beyond the mucosa. In the current
study, we cannot differentiate between an ‘‘outgrowth’’ model in
which multiple variants initially establish a localized infection and
only a single variant can generate a systemic infection, and a
‘‘mucosal barrier’’ model in which the genetic bottleneck is the
result of a single HIV-1 variant with the capacity to penetrate the
mucosal barrier. The observed effect of genital inflammation or
ulceration on transmission of multiple variants could result from an
increase in the overall frequency of localized infections or a more
permeable portal of entry. Nevertheless, it is clear that a single
variant does not universally emerge as the most-fit virus, making it
unlikely that the genetic bottleneck observed in the majority of
linked transmission events is simply a test of viral replication fitness,
as has been previously proposed [30].
That a single variant from the donor quasispecies, or a
genetically restricted subset of variants, establishes infection in
the cohorts studied here has direct implications for interventions
aimed at preventing transmission of HIV-1. Irrespective of the
basis for the genetic bottleneck, the earliest stage of HIV-1
infection represents a narrow window of time when there is highly
restricted diversity in the virus population in which to implement
protective strategies. Additional studies aimed at understanding
the traits that confer the capacity to transmit and establish
infection will be critical for guiding these preventative strategies.
Materials and Methods
Study Subjects
The transmission pairs characterized in this study were enrolled
in the Zambia Emory HIV research Project (ZEHRP) in Lusaka or
Projet San Francisco (PSF) Kigali, which provide voluntary HIV-1
testing and counseling, long-term monitoring and health care to
cohabitating heterosexual couples in the capital cities of Zambia and
Rwanda [10,11]. At each visit the seronegative partner is tested for
seroconversion using Determine and Unigold rapid HIV antibody
tests [13]. Banked plasma samples from the antibody negative
partners were tested for the presence of p24 antigen using the
Beckman Coulter HIV-1 p24 antigen ELISA to identify individuals
during acute infection [14,15,31]. The p24-positive subjects were
tested within a 2 week window for seroconversion. Transmission
pairs were prioritized from all seroconversion events by selecting
first those who were identified as p24-positive and then those in
which the recipients had a seronegative test date within the previous
3 or 4 months. Within these selection criteria, we balanced the
number of FTM and MTF transmissions in order to avoid any
gender bias. There were no transmission pairs for which we were
unable to amplify the env region in both partners. Details regarding
time since enrollment in the cohort, age and viral load at the time of
transmission (where available) for the donor partners are provided
in Table S1, Protocol S1. For the unlinked transmission recipients,
which comprise only 13% of transmissions, we used similar selection
criteria. Viral RNA was extracted from plasma and genomic DNA
was extracted from uncultured peripheral blood mononuclear cells
(PBMC) using blood samples collected by venipuncture into acid
citrate dextrose tubes from both partners on the day at which
infection was confirmed, as described previously [9]. Plasma
samples that were p24 positive were analyzed when available.
Informed consent and human subjects protocols were approved by
the Emory University Institutional Review Board, the University of
Zambia School of Medicine Research Ethics Committee and the
Rwanda Ethics Committee.
The estimated number of days between infection and sample
collection for each newly infected individual was calculated
according the following algorithm. For individuals who were
identified as antibody positive and p24 antigen negative at the date
of sample collection, the estimated date of infection is presented as
less than the number of days between the last seronegative test
date and the first seropositive test date (day of sample collection).
For individuals identified as antibody positive and p24 antigen
positive at the date of seroconversion, the estimated date of
infection was determined as 31 days prior to the date of
seropositive testing (Fiebig stages III and IV, [18]). For individuals
identified as antibody negative and p24 antigen positive, the
estimated date of infection was determined as 22 days prior to that
date (Fiebig stage II), and finally for individuals identified as viral
RNA positive and antibody/p24 antigen negative, the estimated
date of infection was determined as 17 days prior to this sample
date (Fiebig stage I).
End-Point Dilution, Single Genome Amplification of HIV-1
env Genes
For amplification of proviral HIV-1 env genes, genomic DNA
was extracted from uncultured peripheral blood mononuclear cells
(PBMC) using the Qiagen DNA Blood Mini Kit. For amplification
of plasma HIV-1 env genes, RNA was purified from plasma
samples using the Qiagen Viral Isolation Kit and cDNA prepared
using the SuperScript III reverse transcriptase according to the
manufacturer’s instructions. All reverse transcription reactions
were primed using an HIV-specific primer (OFM19, see sequence
below). We were able to amplify viral sequences for all individuals
from whom we attempted PCR amplification.
Full-length gp160 amplicons were obtained from genomic DNA
or plasma cDNA using nested PCR amplification by single
genome amplification [32]. Input genomic DNA or plasma cDNA
was diluted to a limiting concentration such that approximately
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one-third or less of all second-round reactions produced a positive
env amplicon. At this dilution, approximately 90% of the reactions
will have originated from a single virus genome in the reaction
[33]. Nested PCR amplifications were performed using Expand
High Fidelity polymerase according to the manufacturer’s
instructions. Full-length gp160 amplification was performed using
the following primer combinations: First round: sense primer Vif1
(59 – GGGTTTATTACAGGGACAGCAGAG – 39), antisense
primer OFM19 (59 – GCACTCAAGGCAAGCTTTATT-
GAGGCTTA – 39); second round: sense primer EA1 (59 –
CCTAGGCATTTCCTATGGCAGGAAGAAGC – 39), anti-
sense primer EN1 (59 – TTGCCAATCAGGGAAG-
TAGCCTTGTGT – 39). PCR conditions were performed in
50 ml reaction volume with cycling parameters as previously
published [9].
A portion of the final PCR product was analyzed by 1% agarose
gel electrophoresis. Positive PCR reactions were purified using the
QIAquick PCR Product Purification Kit or Exosap according to
the manufacturer’s instructions. Amplicons were directly se-
quenced by Lone Star Labs, Inc. (Houston, TX), Macrogen,
Inc. (Seoul, Korea) or the UAB CFAR DNA Sequence Analysis
Core (Birmingham, AL). Sequencing primers: For14 (59–TATGG-
GACCAAAGCCTAAAGCCATGTG–39) and Rev16 (59–
ATGGGAGGGGCATACATTGCT–39) were used to generate
overlapping sequences of the V1–V4 region of the HIV envelope.
Sequence Analysis
To confirm PCR amplification of a single template, nucleotide
sequence chromatograms were examined for multiple peaks, and
any such amplicons were discarded. Sequences were trimmed to the
first cysteine in V1 and the final cysteine in V4 for further analysis.
Sequences were hand-aligned using MacClade 4.06 then gap-
stripped to generate neighbor-joining trees using Clustal W.
Unrelated reference sequences from the Los Alamos National
Laboratory HIV Sequence Database were used as an outgroup for
phylogenetic trees. Reference sequences represented Subtype A
sequences from Rwanda and Subtype C sequences from Zambia
(Subtype A: AY669706, AY669702, U86544, AB287377,
AY713406, AB287376 and Subtype C: AB254143, AB254146,
AY805330, AF286224, AF286225). The reliability of branching
orders was assessed by bootstrap analysis with 1,000 replicates.
Nucleotide and amino acid pairwise distance calculations for each
recipient virus population was determined using PAUP 4.0b10. The
Highlighter tool (Los Alamos National Laboratory HIV Sequence
Database, http://www.hiv.lanl.gov/content/hiv-db/HIGH-
LIGHT/highlighter.html) was used to further analyze the diversity
in viral variants transmitted to the recipient partner. Aligned
sequences for each recipient were imported into the Highlighter tool
and the master was selected as the sequence representing the most
highly abundant variant in that virus population. Most recent
common ancestor (MRCA) calculations were determined as
previously described [21]. All V1–V4 env sequences from each
newly infected and chronically infected individual were deposited in
GenBank under the accession numbers FJ185853-FJ187678. Full
length gp160 sequences have been deposited for ZM184F
(EU166413-EU166438), ZM215F (EU166544-EU166575),
ZM229M (EU166576-EU166604), ZM247F (EU166779-
EU166856), and ZM249M (EU166857-EU166916) [20].
Analysis of Recipient Clinical Histories
Medical and laboratory signs and symptoms of sexually
transmitted infections (STI) were recorded systematically at
routine quarterly study visits and at interim sick visits, with full
physical and/or genital exams conducted as clinically indicated;
physical and genital exams were routinely conducted on the visit
date when lab test results indicated HIV-1 seroconversion. A self-
reported symptom was considered present whether or not the
patient sought medical treatment and included treatment
administered at external clinics. Composite variables were created
from physical exam, medical and laboratory data for genital
ulceration and genital inflammation. An STI sign or symptom was
included in this analysis if it was reported on the visit date when
HIV-1 seroconversion was detected or within one quarterly study
visit prior to this visit date. Base SASH and SAS/STATH statistical
software was used for data management and analysis; Fisher’s
exact test was used to assess statistical significance of difference in
STI proportions between groups.
Supporting Information
Figure S1 Diversity in individuals infected with multiple
variants. Aligned linked recipient sequences were analyzed by
the Highlighter tool (Los Alamos National Laboratory website -
HIV Sequence Database) for (A) RW57F and (B) ZM229F (C)
ZM224F and (D) ZM215F. Tic marks indicate nucleotide
differences from the indicated master sequences derived from
the recipient. Nucleotide differences are color-coded and are
marked according to their genetic location along the length of V1–
V4. Colors are as follows: A: green, T: red, G: yellow, C: blue and
gaps: gray. Red box indicates signature of 5 synonymous
nucleotide differences between variants that established infection
in RW57F.
Found at: doi:10.1371/journal.ppat.1000274.s001 (1.72 MB PDF)
Figure S2 Diversity in newly infected individuals. Aligned linked
recipient sequences were analyzed by the Highlighter tool (Los
Alamos National Laboratory website - HIV Sequence Database)
for (A) ZM216M and (B) ZM292M. Tic marks indicate nucleotide
differences from the indicated master sequences derived from the
recipient. Nucleotide differences are color-coded and are marked
according to their genetic location along the length of V1–V4.
Colors are as follows: A: green, T: red, G: yellow, C: blue and
gaps: gray. Red box indicates CTL-escape footprint.
Found at: doi:10.1371/journal.ppat.1000274.s002 (1.36 MB PDF)
Table S1 Enrolled Partner
Found at: doi:10.1371/journal.ppat.1000274.s003 (0.05 MB PDF)
Protocol S1 Criteria for defining infection by a single or
multiple variant
Found at: doi:10.1371/journal.ppat.1000274.s004 (0.04 MB PDF)
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